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PORTAL hypertension is generally looked upon as a
result of obstruction to the portal vein, secondary to
hepatic scarring and regeneration resulting from various
parenchymal liver disorders. Less often, the obstruction
follows thrombosis of the portal vein. But there remains
a small group of patients with clear-cut evidence of portal
hypertension in whom the portal vein is normal and the
liver seems suprisingly free of disease (Tisdale et al.
1959). Latterly, Shaldon and his colleagues (1961, 1962),
using a bioassay method found that the level of adrena-
line and noradrenaline in the portal venous blood was
raised in patients with portal hypertension. We tried to
confirm and extend these findings by determining the
catechol amines in plasma fluorometrically (Cohen and
Goldenberg 1957).
Methods
The amount of noradrenaline and adrenaline in portal
venous blood was estimated in 8 unselected patients under-
going portal venous decompression for portal hypertension.
Control samples were also obtained from 8 patients with no
known liver disease and without portal hypertension. In some
of the patients blood from the inferior vena cava also was
analysed for catechol amines. All patients were under general
anaesthesia when the blood-samples were taken. The anaes-
thetic agents used were thiopentone sodium, nitrous oxide,
cyclopropane, and innovan.
60 ml. blood-samples were collected in heparinised syringes,
refrigerated, and then centrifuged at 1500 r.p.m. for twenty-five
minutes. The plasma was removed and placed in contact with 0-5 g.
of activated alumina in 10 ml. of 0-2 N sodium acetate, 0-5 ml. of
0-2 M sodium edetate, and 2-0 ml. of 0-05 M sodium thiosulphate.
To check the method in each run, standards were added to one half
of a divided plasma sample for internal recovery.
The samples were adjusted to pH 8-4 for three minutes with
constant stirring, and the alumina was separated chromatographi-
cally. The adsorbed catechol amines were eluted from the alumina
with 6-5 ml. of 0-2N acetic acid. A 3-0 ml. eluate fraction was then
run as a sample for fluorometric determination. The trihydroxyin-
doles of adrenaline and noradrenaline in this sample were formed
by oxidation with 0-1 ml. of an iodine solution (Crout 1962), in the
presence of an ascorbate-bisulphate-hydroxide solution.
Blanks were prepared from the remaining 3-0 ml. eluate fraction
by failing to add ascorbate and bisulphate to the alkaline oxidation
mixture until the iodoaminochromes of the catechol amines had
deteriorated. These fluorescent substances reach their highest con-
centration after about an hour, and the samples and blanks were
read then on a ’ Farrand ’ model A filter-fluorometer.
For the differential determination of noradrenaline and adrena-
line, the samples and the standards were activated, and fluorescence
was determined at two different wave-lengths (Cohen and Goldenberg
1957). Internal recoveries exceeded 70%. No correction was made
for incomplete recovery.
Results
In 7 of the 8 patients, the portal hypertension was
secondary to hepatic cirrhosis-alcoholic or post-necrotic
in origin-and in 1 (case 8) it was due to an extrahepatic
block. The portal pressures in the 7 cirrhotic patients
ranged from 205 to 460 mm. of saline solution. None of
the control patients had any clinical evidence of portal
hypertension, and in none was there any suggestion of
portal hypertension at operation. None had evidence of
diffuse liver disease. Case 7 had what was believed to
be a solitary hepatic metastasis in a site not accessible
for biopsy, but the rest of his liver was grossly normal,
and there was no laboratory evidence of diminished
hepatic function.
The plasma values of adrenaline and noradrenaline in
the portal venous blood of the portal hypertensive
patients and the controls are shown in tables I and II.
No statistical difference was found between the portal
venous catechol-amine content of patients with portal
hypertension and that of the controls. Moreover, we
could not confirm the finding of Shaldon et al. (1961,
1962) that in portal hypertension the level of catechol
amines was much higher in the portal venous blood than
in blood from the inferior vena cava.
The level of noradrenaline in the portal venous blood
was slightly higher in all the patients in this group than
the level in the systemic arterial plasma of 11 conscious,
resting, cardiac patients with no liver disease or portal
hypertension, and no evidence of myocardial decompen-
sation (noradrenaline, 0-32:0-17 g. per litre; adrena-
line, 0-62 &plusmn;0-53 g. per litre). This higher level of
TABLE I-CATECHOL AMINES IN NORMAL PORTAL BLOOD
(Trihydroxyindole method)
inferior vena cava values: noradrenaline, 0-66 tg. per litre; adrenaline,
1-20 tig. per litre.
tSplanchnic arterial values: noradrenaline, 0-68 g. per litre; adrenaline,
0-80 jjtg. per litre.
noradrenaline in the portal venous blood than in systemic
arterial plasma was found in one control patient (case 3),
in whom the concentration of noradrenaline was deter-
mined in both the splanchnic arterial and portal venous
blood. All patients had higher levels of plasma-adrena-
line in the portal vein and inferior vena cava than the
levels previously reported in peripheral venous blood
(Cohen and Goldenberg 1957, Price and Price 1957,
Vendsalu 1960). In view of the general anxsthesia and
operative procedure each was undergoing when blood-
samples were taken this is not surprising (Price et al. 1960).
Discussion
Catechol amines are known to have adverse effects on
the liver, producing fatty degeneration and necrosis
(Wool et al. 1954, Butler et al. 1959, Brody and Calvert
1960, Calvert and Brody 1960, Brody et al. 1961). Adrena-
TABLE II-CATECHOL AMINES IN PORTAL HYPERTENSION
(Trihydroxyindole method)
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line increases portal venous pressure in normal man,
but not in cirrhotics when there is an initial decrease in
portal pressure (Child 1954). Decreases in blood-flow and
organ volume in the portal system with catechol amines
have been reported (Bayliss 1893, Jarisch and Ludwig
1926, Koch and Nordmann 1928, Gollwitzer-Meier and
Schulte 1931, Heymans et al. 1931, Cannon and Rosen-
blueth 1933, Driver and Vogt 1950, Maegraith 1951).
Recently Shaldon et al. (1961, 1962) have suggested that
catechol amines play an important part in the pathogenesis
of portal hypertension.
The values for portal venous catechol amines in portal
hypertension reported by Shaldon and his coworkers
were higher than those found by Cohen and Goldenberg
(1957) in the peripheral venous blood of patients with
phaeochromocytoma, being at their highest more than
twenty-five times higher than the highest phaeochromo-
cytoma values. Shaldon’s normal values are more than ten
times the values given in published reports (Cohen and
Goldenberg 1957, Price and Price 1957, Vendsalu 1960).
This suggests that Shaldon’s results can be explained by a
difference in method. The trihydroxyindole method of
Lund (1941) as applied by Cohen and Goldenberg (1957)
to the differential analysis of noradrenaline and adrenaline,
which we used, has been shown to be specific for catechol
amines, because the method requires that the compound
to be detected must have a 3, 4, dihydroxphenyl nycleus
with a two carbon side-chain, a terminal nitrogen, and a
hydroxyl group substituted on the &bgr;-carbon atom. This
was confirmed by von Euler (1956).
Price and Price (1957) and Crout (1962) have shown
further that, in addition to the lutines of noradrenaline
and adrenaline, only the lutine of isopropyl noradrenaline
has sufficient detectable fluoresence, and that neither
dopamine, serotonin, nor the known precursors or
breakdown products of noradrenaline or adrenaline
significantly interfere with the analysis of catechol amines.
Siegel et al. 1961 have shown that the trihydroxyindole
method is sensitive and accurate enough to measure the
increase of catechol amines in the coronary veins produced
by stimulation of the cardiac sympathetic nerves, and
also that the chemical assay can be precisely correlated
with the graded inotropic response of the heart. Also,
Siegel and Gilmore (1960) have shown that the trihy-
droxyindole method is sufficiently sensitive to detect the
reflex sympathetic release of catechol amines in barore-
ceptor activity resulting from hypotension. The repeatedly
demonstrated specificity and sensitivity of the method
makes it unlikely that an increase of the concentration of
catechol amines in portal venous blood of the magnitude
reported by Shaldon (1961, 1962) could have been over-
looked. Possibly Shaldon’s results are due to some
other vasoactive principle (detectable by bioassay) in
the portal venous blood of patients with portal hyper-
tension.
Our own results throw no light on the role of catechol
amines in the setiology of cirrhosis of the liver. But, on
the evidence of the specific trihydroxyindole test, we
believe increased portal venous catechol amines are not
responsible in man for the maintenance of the portal
hypertension caused by cirrhosis of the liver or by
extrahepatic portal block.
Summary
In a group of 8 unselected patients with portal hyper-
tension and 8 patients with normal portal circulations the
adrenaline and noradrenaline content of portal venous
plasma was determined fluorometrically. No difference
was found in the portal venous catechol amine content
of these two groups.
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THE two cases of triple-X females described here are of
interest for several reasons. The sex-chromatin abnormali-
ties were discovered during the examination of smears for
malignant cells. In one case, double chromatin (Barr)
bodies were noted in a vaginal smear, and in the other
they were seen in the squamous cells of sputum. The
patients are not (as in many of the published cases)
mentally defective, and they do not have primary or
secondary amenorrhcea. Furthermore, one of them
(case 1) is fertile, like the triple-X females described by
Stewart and Sanderson (1960), Fraser et al. (1960), and
Lewis et al. (1963).
Case 1
A married woman of 37 attends a Family Planning Associa-
tion clinic where it is the practice to examine smears for
malignant cells from all patients over 30. In her vaginal and
cervical smears about 15% of the nuclei of the squamous cells
showed two peripheral chromatin (Barr) bodies. Buccal
smears showed the same percentage of nuclei with two
chromatin bodies. Chromosome preparations of skin and
peripheral leucocytes were made by the methods of Harnden
(1960) and Moorhead et al. (1960). In each preparation the
modal number of chromosomes was 47. There was an addi-
tional chromosome in the 6-12 group, and in view of the buccal
smear findings it is reasonable to assume that the additional
chromosome is an X-chromosome and that the patient’s
sex-chromosome constitution is XXX.
The patient is 5ft. 71/2 in. (171 cm.) tall and weighs 155 lb.
(70-3 kg.). She is an only child and was born when her father
